Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]

Detalles Bibliográficos
Autores principales: Miglietta, F., Bottosso, M., Griguolo, G., Dieci, M.V., Guarneri, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014390/
https://www.ncbi.nlm.nih.gov/pubmed/35398607
http://dx.doi.org/10.1016/j.esmoop.2022.100472
_version_ 1784688190916919296
author Miglietta, F.
Bottosso, M.
Griguolo, G.
Dieci, M.V.
Guarneri, V.
author_facet Miglietta, F.
Bottosso, M.
Griguolo, G.
Dieci, M.V.
Guarneri, V.
author_sort Miglietta, F.
collection PubMed
description
format Online
Article
Text
id pubmed-9014390
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90143902022-04-19 Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409] Miglietta, F. Bottosso, M. Griguolo, G. Dieci, M.V. Guarneri, V. ESMO Open Erratum Elsevier 2022-04-07 /pmc/articles/PMC9014390/ /pubmed/35398607 http://dx.doi.org/10.1016/j.esmoop.2022.100472 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Erratum
Miglietta, F.
Bottosso, M.
Griguolo, G.
Dieci, M.V.
Guarneri, V.
Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]
title Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]
title_full Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]
title_fullStr Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]
title_full_unstemmed Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]
title_short Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]
title_sort erratum to ‘major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [esmo open volume 7, issue 2, april 2022, 100409]
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014390/
https://www.ncbi.nlm.nih.gov/pubmed/35398607
http://dx.doi.org/10.1016/j.esmoop.2022.100472
work_keys_str_mv AT migliettaf erratumtomajoradvancementsinmetastaticbreastcancertreatmentwhenexpandingoptionsmeansprolongingsurvivalesmoopenvolume7issue2april2022100409
AT bottossom erratumtomajoradvancementsinmetastaticbreastcancertreatmentwhenexpandingoptionsmeansprolongingsurvivalesmoopenvolume7issue2april2022100409
AT griguolog erratumtomajoradvancementsinmetastaticbreastcancertreatmentwhenexpandingoptionsmeansprolongingsurvivalesmoopenvolume7issue2april2022100409
AT diecimv erratumtomajoradvancementsinmetastaticbreastcancertreatmentwhenexpandingoptionsmeansprolongingsurvivalesmoopenvolume7issue2april2022100409
AT guarneriv erratumtomajoradvancementsinmetastaticbreastcancertreatmentwhenexpandingoptionsmeansprolongingsurvivalesmoopenvolume7issue2april2022100409

Ejemplares similares